Clairfield International, in collaboration with law firm Luther Rechtsanwaltsgesellschaft, recently released a wide-ranging study of the German medtech market. Medical Technology Market Study 2018 provides a comprehensive overview that illuminates the medical technology market from a legal, technical, and transaction-oriented perspective. Based on key challenges of the growth market, the study analyzes the most important current trends, from technical innovations such as artificial intelligence to the importance of new regulations. The study discusses structures and special features in Europe and the US in addition to the market in Germany. Expert interviews with medtech entrepreneurs provide insights into the current perception of the market from the perspective of market participants.

“Against the background of digitization, increasing cost pressure, and high regulatory requirements, strategic collaborations are becoming increasingly important with regard to data-based services such as AI-based diagnostics,” says Cornelia Yzer, partner and counsel at Luther Rechtsanwaltsgesellschaft,

“As a growth market with a high rate of innovation, the industry is undergoing great change. We anticipate continued market concentration,” says Dirk Freiland, managing partner at Clairfield International. “Currently, about 95 percent of all medtech companies are small and medium-sized companies. To stay fit for the future, these businesses need to be properly positioned, among other things, for emerging markets such as China, India, and Brazil.”

“The long-established market players are also being put under pressure, as more and more companies from outside the industry are pushing into the market – for example from the automotive industry and the IT sector,” says Dr. Ulrich Philippi, partner at Luther Rechtsanwaltsgesellschaft. “SMEs need to review their business models and explore the use of new technologies. New investors or mergers can help.”

Read the report here: Clairfield Medtech Market Survey 2018